We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+17.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$2.26B
AUM Growth
+$384M
Cap. Flow
+$115M
Cap. Flow %
5.09%
Top 10 Hldgs %
22.4%
Holding
443
New
33
Increased
160
Reduced
64
Closed
38

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$39.7M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$14.6M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.1M
4
WLK icon
Westlake Corp
WLK
+$8.6M
5
BKNG icon
Booking.com
BKNG
+$6.85M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$26.3M
2
CELG
Celgene Corp
CELG
+$20.8M
3
TIF
Tiffany & Co.
TIF
+$8.44M
4
SOXX icon
iShares Semiconductor ETF
SOXX
+$7.14M
5
ROP icon
Roper Technologies
ROP
+$5.77M

Sector Composition

Rank Sector Weight
1 Healthcare 30.75%
2 Technology 20.83%
3 Consumer Discretionary 14.53%
4 Financials 9.34%
5 Miscellaneous 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOLD
226
DELISTED
Amicus Therapeutics
FOLD
$1.54M 0.07%
158,600
– –
ALK icon
227
Alaska Air
ALK
$4.45B
$1.53M 0.07%
+22,400
New +$1.53M
JKS
228
JinkoSolar
JKS
$561M
$1.49M 0.07%
65,670
– –
EA
229
DELISTED
Electronic Arts
EA
$1.48M 0.07%
13,652
+8,652
+173% +$859K
ENB icon
230
Enbridge
ENB
$106B
$1.47M 0.07%
37,000
-2,320
-6% -$86.6K
AEM icon
231
Agnico Eagle Mines
AEM
$99.7B
$1.42M 0.06%
23,000
-1,000
-4% -$58.1K
AUPH icon
232
Aurinia Pharmaceuticals
AUPH
$2.15B
$1.41M 0.06%
+66,000
New +$608K
MRTX
233
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.41M 0.06%
11,000
– –
HALO icon
234
Halozyme
HALO
$12.1B
$1.4M 0.06%
77,900
– –
FIS icon
235
Fidelity National Information Services
FIS
$19.3B
$1.4M 0.06%
10,000
– –
BBD icon
236
Banco Bradesco
BBD
$37B
$1.39M 0.06%
208,254
– –
OESX icon
237
Orion Energy Systems
OESX
$110M
$1.39M 0.06%
40,000
– –
WDC icon
238
Western Digital
WDC
$149B
$1.38M 0.06%
29,295
-10,584
-27% -$442K
XLRN
239
DELISTED
Acceleron Pharma
XLRN
$1.38M 0.06%
26,900
– –
SAGE
240
DELISTED
Sage Therapeutics
SAGE
$1.37M 0.06%
18,700
-15,500
-45% -$1.91M
INSM icon
241
Insmed
INSM
$26.2B
$1.37M 0.06%
57,700
– –
MLKN icon
242
MillerKnoll
MLKN
$1.44B
$1.35M 0.06%
32,400
– –
LITE icon
243
Lumentum
LITE
$75.3B
$1.34M 0.06%
16,900
-5,600
-25% -$367K
VECO icon
244
Veeco
VECO
$2.5B
$1.31M 0.06%
88,900
– –
CSX icon
245
CSX Corp
CSX
$90.1B
$1.29M 0.06%
53,175
+900
+2% +$21.3K
LRCX icon
246
Lam Research
LRCX
$339B
$1.29M 0.06%
43,850
+600
+1% +$15.9K
AIG icon
247
American International
AIG
$39.7B
$1.28M 0.06%
25,000
– –
SNPS icon
248
Synopsys
SNPS
$70.5B
$1.27M 0.06%
9,091
+101
+1% +$13.9K
GRFS
249
Grifois
GRFS
$5.01B
$1.26M 0.06%
53,456
– –
IXC icon
250
iShares Global Energy ETF
IXC
$3B
$1.23M 0.05%
39,900
+30,000
+303% +$920K
8 9
10
11 12

Similar funds

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
WI
WealthNavi Inc Shinagawa-Ku, Tokyo, Japan $12.8B AUM 19.73% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Erste Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Erste Asset Management held 443 positions worth $2.26B, up 20% from $1.88B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $115M of net new capital in Q4 2019, opening 33 new positions and adding to 160 existing holdings. Its largest new stake was Westlake Corp: 128,000 shares worth $8.83M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $26.3M trimmed.

  • Erste Asset Management's largest Q4 2019 buy was Westlake Corp: 128,000 shares worth $8.83M.
  • Erste Asset Management added most to Biogen in Q4 2019, an estimated $39.7M increase.
  • Erste Asset Management's biggest Q4 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $26.3M.
  • Erste Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $20.8M.
  • Erste Asset Management's ten largest holdings make up 22% of its $2.26B portfolio in Q4 2019.
  • Erste Asset Management opened 33 new positions and closed 38 in Q4 2019.
  • Erste Asset Management's portfolio value rose 20% quarter-over-quarter to $2.26B.

Based on Erste Asset Management's 13F filing for Q4 2019, filed 22 Nov 2024.